BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//GoodLifeSci - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://goodlifesci.sidley.com
X-WR-CALDESC:Events for GoodLifeSci
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20230312T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20231105T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20240310T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20241103T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20250309T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20251102T070000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240501
DTEND;VALUE=DATE:20240502
DTSTAMP:20260422T123740
CREATED:20240416T162301Z
LAST-MODIFIED:20241118T220313Z
UID:1910-1714521600-1714607999@goodlifesci.sidley.com
SUMMARY:Boston Life Sciences Roundtable
DESCRIPTION:Join Sidley at our annual Boston Life Sciences Roundtable for an afternoon of engaging discussion addressing cutting-edge trends and hot topics. \n \n1:30 p.m. Registration | 2:00 p.m. Program | 5:00 p.m. Reception\nFor more information\, contact bosevents@sidley.com. \nFEATURED PANEL TOPICS\n\nI Used To Practice Law: A Conversation with Life Sciences Leaders\nA rare few life sciences leaders have served in both chief legal and chief business officer roles during the course of their careers.  Join our discussion of making the transition  \n\n\n\nAnna Barry\, Venture Partner\, Deerfield Management\nJerald Korn\, Chief Executive Officer\, Ropirio Therapeutics\, Inc.\nAsher Rubin\, Partner\, Global Co-leader\, Technology and Life Sciences Transactions\nBecky Wood\, Partner\, Global Co-leader\, Food\, Drug and Medical Device and former FDA Chief Counsel\n\n\n\nStrategies for Success: Navigating Current Healthcare and FDA Trends for Life Sciences Companies\nThe session will cover hot topics and regulatory developments from both an FDA and healthcare perspective. \n\n\n\nScott Kaplan\, Deputy General Counsel\, Baxter International Inc.\nPeter Smith\, Head of Legal\, argenx US\, Inc.\nDonielle McCutcheon\, Partner\, Healthcare\nJim Johnson\, Partner\, Food\, Drug and Medical Device\n\n\n\nLife Sciences Transactions: Updates and Perspectives on the Market\nFrom green shoots and increased deal activity to supply chain disruptions and Congressional investigations\, this panel will explore important updates affecting the environment for life sciences transactions. \n\n\n\nAndy Meyerson\, Managing Director\, Locust Walk\n\nJason Russell\, Managing Director\, Global Head of Biotechnology\, Morgan Stanley\nMichael Borden\, Partner\, Leader\, Government Strategies\nAlison Lehner\, Partner\, Emerging Companies and Venture Capital\nAdriana Tibbitts\, Partner\, Technology and Life Sciences Transactions
URL:https://goodlifesci.sidley.com/event/boston-life-sciences-roundtable-3/
LOCATION:MassBio Hub\, 700 Technology Square\, Cambridge\, MA 02139
ATTACH;FMTTYPE=image/jpeg:https://goodlifesci.sidley.com/wp-content/uploads/sites/6/2022/06/MN14393-Boston-Life-Sciences-Event-Banner-865px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Chicago:20240507T080000
DTEND;TZID=America/Chicago:20240507T093000
DTSTAMP:20260422T123740
CREATED:20240321T150358Z
LAST-MODIFIED:20240321T150358Z
UID:1872-1715068800-1715074200@goodlifesci.sidley.com
SUMMARY:ICCA 2024 Hong Kong Sidley Breakfast Seminar
DESCRIPTION:Join us for an engaging and informative panel discussion on life sciences disputes as part of ICCA 2024 Hong Kong. Our panel comprising Sidley disputes and life sciences specialists as well as inhouse counsel will explore (i) general trends in life sciences transactions\, (ii) the complexities and unique challenges involved in life sciences disputes with a focus on IP and cross-border issues\, (iii) strategies on how to avoid and manage potential disputes in life sciences transactions\, and (iv) case studies and practical insights. \nRSVP Here \n \n8:00 a.m. HKT: Registration\n8:30 – 9:30 a.m. HKT: Panel discussion \nOur international panel of specialists will comprise partners from Sidley’s Global Arbitration\, Trade and Advocacy and Global Life Sciences practices\, as well as representatives from the life sciences industry.
URL:https://goodlifesci.sidley.com/event/icca-2024-hong-kong-sidley-breakfast-seminar/
LOCATION:The Clipper\, The American Club\, Floors 48-49\, Two Exchange Square\, Central\, Hong Kong
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240514T130000
DTEND;TZID=America/New_York:20240514T140000
DTSTAMP:20260422T123740
CREATED:20240502T211916Z
LAST-MODIFIED:20240502T212138Z
UID:1923-1715691600-1715695200@goodlifesci.sidley.com
SUMMARY:FDA’s New Wave of Promotion Enforcement: What You Need to Know Now
DESCRIPTION:After several years of relatively little enforcement\, FDA has recently been flexing its muscles in the promotion area. The Office of Prescription Drug Promotion (OPDP) in particular has issued several notable warning and untitled letters in the past year\, representing an increased volume in enforcement and increased scrutiny of efficacy claims. This includes more rigorous assessment of information “consistent with” FDA-required labeling (CFL) and enforcement of new expectations for presentation of quantitative efficacy information. Tune in to this overview session for an efficient rundown of what this means for drug\, biological product\, and device manufacturers in terms of key watchouts and practical approaches to risk mitigation. \nRSVP here.\n \n1:00 p.m. – 2:00 p.m. ET \nCLE credit will be offered for this webinar.\nSidley Austin LLP is an accredited MCLE provider in IL\, NY\, and CA. Credit is available for CT\, NJ\, TX\, and VA upon request.
URL:https://goodlifesci.sidley.com/event/fdas-new-wave-of-promotion-enforcement-what-you-need-to-know-now/
LOCATION:MA
END:VEVENT
END:VCALENDAR